Corient Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.01M | Sell |
16,867
-5,019
| -23% | -$2.68M | 0.01% | 590 |
|
|
2025
Q1 | $13.9M | Sell |
21,886
-998
| -4% | -$633K | 0.02% | 448 |
|
|
2024
Q4 | $16.3M | Sell |
22,884
-4,349
| -16% | -$3.1M | 0.03% | 425 |
|
|
2024
Q3 | $28.6M | Buy |
27,233
+4,992
| +22% | +$5.25M | 0.04% | 336 |
|
|
2024
Q2 | $23.4M | Sell |
22,241
-12,188
| -35% | -$12.8M | 0.04% | 360 |
|
|
2024
Q1 | $33.1M | Buy |
34,429
+868
| +3% | +$835K | 0.06% | 292 |
|
|
2023
Q4 | $29.5M | Buy |
33,561
+2,537
| +8% | +$2.23M | 0.05% | 317 |
|
|
2023
Q3 | $25.5M | Buy |
31,024
+823
| +3% | +$677K | 0.06% | 299 |
|
|
2023
Q2 | $21.7M | Sell |
30,201
-980
| -3% | -$704K | 0.05% | 316 |
|
|
2023
Q1 | $25.6M | Buy |
31,181
+16,479
| +112% | +$13.5M | 0.07% | 268 |
|
|
2022
Q4 | $10.6M | Buy |
+14,702
| New | +$10.6M | 0.04% | 360 |
|